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Ovarian follicle development is controlled by the cycling variation of gonadotrophins derived from the central nervous
system. Intragonadal signals are also required, especially in the autonomous development of small follicles. Receptor
tyrosine kinase c-kit and its ligand SLF (Steel factor) are expressed on the surface of speci®c populations of follicle-forming
cells in a contiguous manner and are thought to have important roles in follicular development. We blocked the interaction
of c-kit and its ligand by administering the function-blocking antibody ACK2 to developing mice at various times after
birth and monitored ovarian follicle development. A blockade of c-kit function disturbed the onset of primordial follicle
development, primary follicle growth, follicular ¯uid formation of preantral follicles, and penultimate-stage ovarian follicle
maturation before ovulation. Ovarian follicle growth was dependent on c-kit during the ®rst 5 days after birth when the
functional FSH receptor is not yet expressed in mouse ovary. In contrast, primordial follicle formation and survival, small
preantral or antral follicle development, ovulation, and luteinization of the ovulated follicle were not affected by this
antibody. These ®ndings indicate the stepwise requirement of c-kit and its ligand interaction system in the developing
ovarian follicle and that c-kit with its ligand supports the autonomous development of ovarian follicle independent of
gonadotrophins. q 1997 Academic Press
INTRODUCTION follicular maturation leading to ovulation, though most of
them do not complete this course and are eventually termi-
In the mouse, female germ cells complete mitotic divi- nated in atresia. The growth of any given follicle appears
sions and begin to enter meiosis before birth. This prenatal to begin with the enlargement of the primary oocyte (still
meiotic process is arrested at prophase I, and each germ cell arrested in meiotic prophase), the proliferation of sur-
is surrounded by a single layer of a few granulosa cells to rounding granulosa cells, and the organization of theca cells
form primordial follicles during a few perinatal days (Peters, external to the basement membrane (Peters, 1969; Pedersen,
1969). From this stage, the development of female germ 1970). During follicular maturation, oocytes increase in size
cells, or oocytes, proceeds with granulosa cells and some and accumulate mRNAs and proteins for early embryonic
other somatic cells surrounding them in the ovarian follicle development (Bachvarova, 1985). In association with oocyte
as a unit (for review, Richards, 1980; Hirsh®eld, 1991). development, granulosa cells not only proliferate rapidly
Those primordial follicles reside within the ovary until but also differentiate and contribute to follicular matura-
some signal triggers their growth. Once the primordial folli- tion.
cles are activated, they start to follow the course typical of It has been proposed that gonadotrophins' cyclic variation
plays an important role in the development of ovarian folli-
cles. These pituitary-derived peptide hormones are ascribed1 To whom correspondence should be addressed. Fax: 81-75-751-
4169; E-mail: hyoshida@virus.kyoto-u.ac.jp. roles in the initiation and maintenance of follicular growth
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and in the selection of the dominant follicle and its matura- al., 1992; Yoshida et al., 1993, 1996), the timing of the
blockade of c-kit signal during ovarian follicle developmenttion to preovulatory status (for review, Richards, 1980). On
the contrary, signi®cant numbers of studies indicate that can be controlled by the schedule of the ACK2 injection.
This study showed that c-kit and its ligand are required forthe dynamic events of follicular growth may not be ac-
counted for completely by the changing levels of these pitu- distinct steps of ovarian follicular development, and that
the cellular consequences of this blockade vary accordingitary hormones. Hypophysectomy, even without hormone
replacement, does not prevent the entry of small follicles to the developing stage of the ovarian follicles.
into the growing pool (Hardy et al., 1974). There are many
small growing follicles even in the ovary of the hpg/hpg
mouse, which is a deletion mutant of the GnRH (gonadotro- MATERIALS AND METHODS
phin-releasing hormone) with no serum gonadotrophin ac-
tivities (Halpin et al., 1986). Kendall et al. (1995) have re- Mice
ported that targeted disruption of pituitary glycoprotein
BDF1 mice were obtained from Shimizu Experimental Animalshormone a-subunit also allows the ovarian follicle develop-
Laboratory Co. and maintained in our laboratory. Female mice werement to the preantral stage. These reports indicate that
mated with males overnight, and noon of the day when a vaginal
there is an intragonadal autoregulatory factor that initiates plug was recognized was dated 0.5 day postcoitum (dpc). Two or
and stimulates the growth of primary follicles independent three pregnant mice of the same dpc were maintained together in
of gonadotrophins. cages so that they would nurse each other's offspring.
A number of signaling receptors such as receptor tyrosine
kinases, serine±threonine kinases, cytokines, and G-pro-
Antibodytein-coupled and steroid hormone receptors are expressed
in ovarian follicle cells, and some may function during folli-
Four independent hybridoma cell lines producing the anti-mouse
culogenesis, particularly during the early stage (for review, c-kit monoclonal antibody ACK2 (Nishikawa et al., 1991), anti-
Tonetta et al., 1991; Ackland et al., 1992; Giordano et al., mouse c-fms monoclonal antibody AFS98 (Sudo et al., 1995), anti-
1992; Richards, 1995). mouse platelet-derived growth factor (PDGF) receptor a mono-
From this viewpoint the most intriguing ®nding in this clonal antibody APA5 (Takakura et al., 1996), and anti-mouse ¯k1
monoclonal antibody AVAS12 a (Kataoka et al., unpublished) were®eld was that receptor tyrosine kinase c-kit and its ligand
incubated with serum-free medium in roller bottles, and all theSLF (Steel factor, also known as MGF, mast-cell growth
conditioned media were puri®ed as described (Nishikawa et al.,factor; KL, kit ligand; or SCF, stem-cell factor), allelic to
1991). The puri®ed antibodies were dissolved in PBS (pH 7.4) at aDominant-spotting (Geissler et al., 1988; Chabot et al.,
concentration of 2 mg/ml for injection. PBS alone was also used as1988; Hayashi et al., 1991) and Steel (Copeland et al., 1990;
the control injection.Huang et al., 1990; Zsebo et al., 1990) loci, are expressed
in developing ovarian follicles from the early to the fully
mature stages in a contiguous manner (Manova et al., 1990, BrdU Injection
1993; Motro et al., 1991; Motro and Bernstein, 1993). Al-
1,4*,5*-Bromodeoxyuridine (BrdU) (Nacalai) was dissolved in PBSthough deletion mutants of c-kit or SLF have defects in
at a concentration of 2 mg/ml, and about 20 mg/g body weight wasprimordial germ cell development and have almost no germ
injected intraperitonially into the experimental animals 2 hr beforecells in their gonads at birth (Mintz and Russell, 1957; Be-
sacri®ce by cervical dislocation.
nett, 1956; McCoshen and McCallion, 1975), there are some
other alleles of Steel (Mgf) mutants with more speci®c de-
fects in postnatal ovarian folliculogenesis (see review, Be- Immunohistochemistry
smer et al., 1993). Mgf Sl-t or Mgf Sl-pan mutants have defects
Histological or immunohistochemical procedures were basicallyin postnatal ovarian follicle development (Terada et al.,
as described (Yoshida et al., 1993). To detect the BrdU incorporated1985; Kuroda et al., 1988; Huang et al., 1993). Growth of
into double-strand DNA, dewaxed sections were microwave irradi-these mutant ovarian follicles is arrested at a less mature
ated for 3 min at 500 W in 10 mM citrate buffer (pH 6.0) and
stage than in hpg/hpg mice and does not respond to hor- immersed in 2 N hydrochloride for 15 min at 407C before immu-
mone replacement therapy (Kuroda et al., 1988). These ob- nohistostaining with the anti-BrdU antibody BR-3 (CALTAG).
servations indicate that SLF and c-kit play roles not only
in the development of primordial germ cells but also in
postnatal ovarian folliculogenesis. Classi®cation of Follicles
The aim of this study was to determine in which process
A classi®cation of oocytes and follicles has been proposed (Ped-during the stepwise development of ovarian folliculogenesis
ersen and Peters, 1968) which is based (1) on the size of oocyte, (2)
is c-kit interaction with its ligand involved. We used the on the size of the follicle as de®ned by the number of granulosa
anti-murine c-kit antibody ACK2. Since we demonstrated cells (represented by the number of cells seen on the largest cross
that an injection of ACK2 into mice at an appropriate dose section of the follicle) and (3) on the morphology of the follicle.
inhibits the functions of c-kit (Nishikawa et al., 1991; We used this classi®cation method and, in brief, the follicles were
divided into:Ogawa et al., 1991, 1993; Yoshinaga et al., 1991; Maeda et
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Type 3a: Small (diameter less than 20 mm) or growing (diameter Experimental Schedule and Discriminating the
20±70 mm) oocyte surrounded by a ring of granulosa cells (not more Mouse Ovarian Follicle Developmental Stage for
than 20 cells on the largest cross section). Experiment
Type 3b: Growing oocyte surrounded by a ring of 20±60 granu-
Despite reports describing the contiguous expression oflosa cells.
Type 4: Growing oocyte surrounded by two layers of granulosa c-kit and its ligand mRNA or proteins in speci®c ovarian
cells (60 to 100 cells on the largest section). follicle cells (Manova et al., 1993; Motro and Bernstein,
Type 5a: A transitory stage between medium and large follicles. 1993), we did not ®nd signi®cant results in a study of ovar-
The oocyte which might be a growing or a larger (diameter 70 mm) ian follicle development in the ovaries of mice administered
one is enveloped in three layers of granulosa cells (100 to 200 cells ACK2 (Yoshinaga et al., 1991). However, histological obser-
on the largest cross section). vation of the estrous cycling mouse ovary sometimes causes
Type 5b: A large oocyte surrounded by many layers of granulosa
confusion because there are too many follicles at differentcells (200 to 400 cells on the largest cross section).
stages, including those developing from primordial toType 6: A large oocyte with many layers of granulosa cells (400
Gra®an follicles, atretic follicles, or corpus luteum (Rich-to 600 cells on the largest cross section).
ards, 1980). To determine c-kit function at distinct stagesType 7: A follicle (more than 600 cells on the largest cross sec-
of ovarian follicle development in vivo, we segregated im-tion) with a single cavity of follicle ¯uid. The cumulus oopherus,
but not its stalk, has formed. mature mice at various ages younger than 4 weeks, which
Type 8: A large follicle with a single cavity of ¯uid and a well- have synchronous ovarian follicle development (Peters,
formed cumulus stalk (preovulatory follicle). 1969), as the following groups.
The numbers of naked or primordial ovarian follicles classi®ed First, to see the primordial follicle formation and primary
into Type 1 or Type 2 of this classi®cation were not counted. follicle development, we have injected ACK2 into neonatal
and infantile embryos 2 weeks after birth. Second, to deter-
mine the function of c-kit during preantral to antral follicle
development, we injected ACK2 into late infantile stage
mice from 10 to 14 days.RESULTS
Third, 2- to 3-week-old mice were used to determine
whether or not the c-kit function blockade affects antral
follicle survival, because spontaneous atresia of antral folli-c-kit Expression in the Developing Female Gonad
cles frequently occurs at early juvenile stage. Finally, to
determine c-kit function around ovulation, ACK2 was in-Since there are several descriptions of c-kit expression
jected into premature mice from 3 to 4 weeks of age, withduring mouse ovarian follicle development (Manova et al.,
a combination of exogenous gonadotrophins (PMSG and1990, 1993; Manova and Bachvarova, 1991; Motro et al.,
hCG) to induce ovulation.1991; Motro and Bernstein, 1993; Horie et al., 1991), we
In a pilot study, injection of 100 mg ACK2 every 2 daysdescribe it here brie¯y.
starting from the day of birth signi®cantly attenuated thePrimordial germ cells expressing c-kit during migration
ovarian follicle development until 4 weeks of age (Maedadiminish expression levels after entering the genital ridges
et al., unpublished observation). The same dose of antibodyand cease to express it at around 14.5 dpc (Matsui et al.,
was used by means of intraperitonial injection, when the1990; Manova and Bachvarova, 1991; Horie et al., 1991).
suckling mice less than 2 weeks after birth were examined.Oocytes begin to form ovarian follicles with granulosa cells
After a few trials with variable doses of ACK2 administra-at 17.5 dpc, and a few days after birth are required to com-
tion, we concluded that 500 mg of antibody for each mouseplete primordial follicle formation in the ovary (Peters,
at more developed stages would obtain the optimal effects1969; Byscov, 1985). c-kit is again expressed on oocytes in
with minimum dose.the female mouse from 17.5 dpc (Fig. 1A), and all oocytes
BrdU was intraperitonially injected into all mice 2 hrin the ovary express it until the day of birth (Fig. 1B).
before sacri®ce.From Day 6 or 7 after birth, distinct theca cells encircling
the largest developing follicles in these infant ovaries be-
come apparent, but they actually start to express c-kit on
Schedule 1: Effect of c-kit Blockade on Primordialtheir surface only after antrum formation which usually
Follicle Formation and Primary Ovarian Folliclestarts around 2 weeks after birth. Therefore, during the ®rst Development10 days after birth, oocytes are the only cells expressing c-
kit in the ovary (Fig. 1C). During the ®rst 2 weeks after birth, about 5 to 10% of the
From juvenile stage (from 2 weeks after birth), oocytes, ovarian follicles of mice ovaries develop in a synchronous
theca cells, and interstitial cells also begin to express c-kit manner (Peters, 1969). We observed the ®rst 2 weeks of
(Fig. 1D). Theca cells of atretic follicles tend to express more ovarian follicle development with ACK2 administration. A
c-kit intensively than developing follicles of the same stage diagram of antibody injection schedule is shown in Fig. 2.
(Fig. 1E). These complex expression pro®les of c-kit in the The predicted results were obtained from the mice given
antibody every 2 days from birth to Day 12 (group 1 in Tableovary usually continue throughout reproductive life.
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FIG. 1. Expression of c-kit in the developing mouse ovary detected by immunohistochemistry with the anti c-kit antibody ACK2. (A) 17.5
dpc. c-kit expression on some naked oocytes. (B) Day of birth. Expression of c-kit in all oocytes including naked and intrafollicular types. (C)
Ten days after birth. Expression of c-kit on oocytes in developing and residing follicles. Theca cells do not express c-kit at this stage. (D) Six
weeks after birth. (E) Expression of c-kit of various stages of oocytes developing in follicles and theca cells of antral or degenerating follicles.
Arrows, expression of c-kit on theca cells; arrowheads, intense expression of c-kit on degenerating follicle theca cells.
1a or Fig. 2). In contrast to the variable stages of developing (Figs. 3A and 3B), almost all the primordial follicles in the
ovaries of group 1 mice seemed not to have begun develop-follicles with many DNA-synthesizing granulosa cells ex-
panding in the ovaries of 14-day mice injected with PBS ment, though all the oocytes were encircled with a single
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almost completely blocked primordial follicle development
for 2 weeks after birth and blocked small follicle survival (Figs.
4D, 4E, and 4F, group 5).
All of the above ACK2-injecting experiments were carried
out three times and the same results were observed.
The Effects of Class-Matched Control Antibody
Injection
Continuous injection of ACK2 during the ®rst 2 weeks
after birth even with up to 300 mg every 2 days showed no
effect on growth or behavior of injected mice during these
2 weeks (data not shown). However, ACK2 injection had
multiple effects on the development of other lineage cells;FIG. 2. Experimental schedule for injecting ACK2 into developing
for instance, it blocked the development of interstitial cellsmice during the ®rst 2 weeks. One hundred micrograms of ACK2
of Cajal and induced digestive tract paralysis in speci®cwas injected each time. The main effects of antibody treatment at
strain background (Maeda et al., 1992), or it depleted thethis stage were blockade of primary follicle development or block-
ade of antrum formation. erythroblast population in adult bone marrow within 4 days
and induced anemia when the mature erythrocytes went
the way of nature (Ogawa et al., 1991).
In order to eliminate the possibility of indirect effect of
those systemic effects of ACK2 on ovarian follicle develop-layer of granulosa cells (Fig. 3C). BrdU incorporation showed
that granulosa cells encircling these oocytes did not exten- ment, the class-matched (rat immunoglobulin g2) antibod-
ies AFS98, APA5, and AVAS12 a, recognizing the extracel-sively synthesize DNA, although some of them changed
from a squamous to a cuboidal form (Fig. 3D). In addition, lular domain of c-fms (Sudo et al., 1995), PDGF receptor a
(Takakura et al., 1996), and Flk1 (Kataoka et al., unpub-many degenerated follicles containing cuboidal granulosa
cells without oocytes were found in the central region of lished) were puri®ed, conditioned, and injected every 2 days
from birth to Day 12.the ovary.
To de®ne the stage at which c-kit is required during pri- Since AFS98 blocks the ligand binding to c-fms (Sudo et
al., 1995), continuous injection of AFS98 into neonatalmary follicle development, the injection timing of the
ACK2 was modi®ed during these 2 weeks. mouse induced the severe osteopetrosis similar to congeni-
tal osteopetrosis mouse Csfmop/Csfmop, defective for c-fmsInjecting antibody every 2 days from Days 2 to 12 only
slightly disturbed ovarian follicle development (Fig. 4A, group ligand (Yoshida et al., 1990 and unpublished). APA5 blocked
the ligand binding to PDGF receptor a and this schedule of2). This suggested that the c-kit function of the ®rst few days is
essential for primary ovarian follicle development. Practically, antibody administration induced severe growth retardation
and was lethal for mice before weaning probably because ofthe ®rst 5 days of c-kit function were important for ovarian
follicle development. A one-time injection of ACK2 at birth renal failure (Takakura et al., 1996).
Despite these severe systemic effects of AFS98 or APA5attenuated ovarian follicle development only slightly (group
3, Fig. 4B), but two injections during the 3 days after birth on postnatal mouse development, a lot of developing sec-
ondary follicles were found in these antibody-treated mouseblocked the development of many follicles (group 4, Fig. 4C).
Three injections of antibody at 0, 2, and 4 postnatal days ovaries at Day 14 in contrast to ACK2-treated mouse ova-
TABLE 1a
Classi®cation of the Developing Follicles in the Ovaries of Day 14 Mice Treated with ACK2 during 2 Weeks after Birth
3a 3b 4 5a 5b
Control 367 { 11 230 { 21 217 { 27 147 { 30 18 { 10
Group 1 291 { 14* 0 0 0 0
Group 2 268 { 42* 118 { 56* 87 { 23* 21 { 10* 0
Group 5 410 { 61 13 { 8* 0 0 0
Group 7 390 { 18* 285 { 64* 139 { 18* 21 { 4* 0
Note. Control group mice received PBS peritoneal injection every 2 days from Day 0 to 12. Mean number { SD; n  6 (from three mice)
for each group.
* P  0.05 (Student's t test).
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FIG. 3. Histological appearance of the ovaries of 14-day-old mice given ACK2 according to various schedules. (A) Normal control mouse
ovary. There are small antral follicles with full-grown oocytes. (B) Incorporation of BrdU into granulosa and theca cells of normal control
mouse ovarian follicles. Arrowheads indicate the primordial follicles at dormant stage. (C) Blockade of primary follicle development in
the ovary of a mouse injected ACK2 at Days 0, 2, 4, 6, 8, 10, and 12 (group 1). (D) Incorporation of BrdU into a few primary follicle
granulosa cells with cuboidal shape in the ovary of group 1 mouse. Arrows indicate the primary follicles with cuboidal-shaped granulosa
cells. A part of the granulosa cells of these follicles incorporated BrdU. Arrowheads indicate the primordial or very early primary follicles
with squamous-shaped granulosa cells. Note that a granulosa cell of a follicle incorporated the BrdU, indicating the onset of follicle
development.
ries (compare Table 1b with group 1 or group 5 in Table 1a). development but attenuated the development or survival of
Actually, some of the suckling mice given APA5 died before all the ovarian follicles. To quantify the difference between
Day 14, but high numbers of secondary follicles were found this group and the control, we calculated the numbers of
in the ovaries of the mice that died (data not shown). developing follicles in serial sections of the whole ovary
Continuous injection of AVAS12 a, which recognizes but and classi®ed them as described by Pedersen and Peters
does not block the function of Flk1 under in vitro or in (1968). The developmental stages of surviving follicles in
vivo conditions (Kataoka et al., unpublished), showed no group 2 mice ovaries appeared to be a few days later than
signi®cant effect on growth, behavior, or viability of mice those of littermate control mice and only a few small antral
and had almost no effect on ovarian follicle development follicles were found, in contrast with a lot of antral follicles
(Table 1b). present in the control mouse ovaries (compare Figs. 3A, 3B,
and 4A).
Schedule 2: Effect of c-kit Function Blockade on To determine whether or not c-kit has a speci®c role in
Antrum Formation during Secondary Follicle antrum formation, ACK2 was injected between Days 10 and
Development 14. All of these procedures signi®cantly suppressed prolifer-
ation and DNA synthesis of granulosa cells in the secondaryAs described above, ACK2 administration from Day 2 to
12 after birth did not block the onset of primary follicle follicles. Antrum formation was severely disturbed by con-
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tinuous antibody injection to produce perturbed ovarian fol- day for 1 week. Although the general appearance of the
histological section did not reveal remarkable changes likelicles with only two layers of granulosa cells surrounding
the full-sized oocyte (groups 6 and 7; Figs. 5A, 5B, and 5C). the case of our previous study (data not shown; Yoshinaga
et al., 1991), the number of classi®ed developing follicles
in serial sections decreased in a manner comparable to that
Schedule 3: Effect of c-kit Function Blockade on of primary and large antral follicles in the experimental to
Spontaneous Antral Follicle Atresia during Early control groups (Table 3).
Juvenile Stage
Ovarian follicles that start to grow during neonatal or
Long-Term Effect of c-kit Function Blockade oninfantile stages do not completely mature. Usually most of
Ovarian Developmentthose growing follicles with a small antrum spontaneously
enter atresia about 3 weeks after onset of follicle growth;
Many developing follicles are found in the ovaries at 3probably the premature endocrine environment does not
weeks of age or in older mice given ACK2 during the ®rstallow them to mature (Peters, 1969). A blockade of the c-
5 days after birth (data not shown). Two mice from eachkit function in this stage, from Day 15 to 21, also attenuated
experimental group given antibody were paired with normalthe small preantral follicle growth, when the numbers of
BDF1 male mice to examine their fertility for the followingovarian follicles were calculated at Day 22, but did not ac-
4 months. Every mouse became pregnant and had one orcelerate or rescue the spontaneous follicle-atresion process
two litters of offspring within this period.(data not shown).
Histological observation of 1-year-old mice given anti-
body revealed no ovarian tumor formation such as develops
Schedule 4: Effect of c-kit Function Blockade on in the Mgf or Kit mutant ovaries with no oocyte remaining
Preovulatory Ovarian Follicle Development (Murphy, 1972; Murphy and Beamer, 1973; Terada et al.,
1985). These results suggested that the blockade of c-kitAt the late juvenile stage, large antral follicles mature to
function by ACK2 administration in this study did not de-the ovulatory stage upon exogenous gonadotropin adminis-
plete c-kit-expressing oocytes in dormant ovarian follicles.tration. An injection of 5 IU PMSG at Day 24 after birth
To determine the effect of a continuous blockade of c-kitcombined with 5 IU hCG 48 hr later induced ovulation in
function on ovarian follicle survival, we tried to continueBDF1 strain mice (Fig. 6A; Table 2, control). We combined
the administration of ACK2 from birth to maturity. How-this ovulation induction with injection of ACK2 to under-
ever, probably because of the anemic lethality caused bystand the roles of c-kit at this stage. All the ovaries were
ACK2, we could not continue injections of 100 mg antibodyharvested 48 hr after hCG injection (at Day 28). For control
every 2 days for more than 5 weeks after birth. Ovarianstudy, PBS or AVAS12 a was administrated. A diagram of
follicle development was severely attenuated in these con-this treatment is displayed in Fig. 7.
tinuously treated groups. However, some small developingIn a pilot study, daily injection of ACK2 from Day 24 to
follicles remained at the end of their life span (data not27 induced the growth arrest or degeneration of preantral
shown).follicles or some antral follicles and reduction of the ovu-
lated oocyte numbers counted in oviducts (Table 2, group
1). But there still remained signi®cant numbers of rather
small developing antral follicles. We administrated the anti- DISCUSSION
body to mice at various times during this ovulation induc-
tion. A blockade of c-kit function by injecting ACK2 be- Speci®city of the Anti-c-kit Antibody
tween 12 and 24 hr before hCG induced the preovulatory Administration Effects on Ovarian Follicle
follicle atresia and resulted in ovulation failure (Fig. 6B; Development
Table 2, group 5). An earlier injection of antibody had a
rather weak or negligible effect on antral follicle degenera- Present results indicated the blockade of c-kit function
by means of function-blocking antibody administration in-tion (Table 2, groups 3 and 4).
No developmental defect was apparent in the luteinizing duced the failure of postnatal mouse ovarian follicle devel-
opment. In order to de®ne the present results of our anti-process when the antibody was injected at the same time
or later than hCG (Table 2, groups 6 and 7). In addition, c-kit antibody administration on ovarian follicle develop-
ment as speci®c and direct effects, we compared the effectsthe incorporation of BrdU into cells of the corpus luteum
seemed comparable with that of the control group (data not administration of three other antibodies on ovarian follicle
development. All three rat monoclonal antibodies wereshown).
Primary follicle development was, however, always dis- class matched to ACK2, and they recognized the extracellu-
lar domain of speci®c receptor tyrosine kinase moleculesturbed by ACK2 around this ovulatory period.
The blocking effects of ACK2 on various stages of ovarian expressed on speci®c cell surface like c-kit. Two of them,
AFS98 (Sudo et al., 1995) and APA5 (Takakura et al., 1996),folliculogenesis were also found in the ovaries of 8-week-
old adult mice injected with 500 mg of the antibody every had severe systemic effects but the remaining one, AVAS12
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FIG. 4. (A) Attenuated development of ovarian follicles of mouse injected with ACK2 on Days 2, 4, 6, 8, 10, and 12 (group 2). There are
rather small antral follicles. (B) Slightly attenuated development of ovarian follicles of mouse injected with ACK2 at day of birth only
(group 3). (C) Severely disturbed development of ovarian follicle of the mouse treated with ACK2 at Days 0 and 2 (group 4). (D) Blockade
of primary follicle development in the ovaries of mice injected with ACK2 at Days 0, 2, and 4 (group 5). (E) Incorporation of BrdU into a
few cells in the primordial or small follicles of mice of group 5.
a (Kataoka et al., unpublished), had no apparent effect on uous injection of AVAS12 a showed that the injection of
rat immunoglobulin g2 class itself has almost no effect onposnatal development of mice.
Almost normal ovarian follicle development with contin- primary or secondary follicle development. A lot of second-
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TABLE 1b
Peritoneal Injection of 100 mg of APA5, AFS98, or AVAS12 a from Day 0 to 12 in the Same Manner Used with Group 1 in Fig. 2,
ACK2 Injection
3a 3b 4 5a 5b
AVAS12 a 339 { 51 241 { 58 179 { 63 81 { 44* 14 { 6
APA5 375 { 44 288 { 33* 124 { 45* 34 { 16* 0
AFS98 357 { 52 302 { 48* 242 { 60 68 { 22* 0
Note. Total number of ovaries examined was four in these control antibody-injected groups. Mean number { SD. n  4 (from two mice)
for each group.
* P  0.05 (Student's t test).
ary follicle development with continuous injection of istration schedule, primordial follicle formation was not
AFS98 or APA5 suggested that the various abnormal sys- disturbed. This indicated that the controlling mechanism
temic conditions including osteopetrosis (Yoshida et al., of this step is independent of c-kit. This kinetic process
unpublished), growth retardation, or severe renal failure may be controlled by some other adhesion molecule ex-
(Takakura et al., 1996) induced by antibodies unrelated to pressed on the surface of somatic cells in the newborn
c-kit did not alter the primary or secondary ovarian follicle mouse ovary (Frojdman and Pelliniemi, 1995).
development. These results suggested the speci®city of In contrast, primordial and small follicle development
ACK2 injection effects on ovarian follicle development. extensively depended on c-kit and its ligand interaction.
Considering the above-mentioned results, we thought the The ®rst 5 days of continuous ACK2 injection completely
present results of ACK2 administration must be induced by blocked the onset of peripheral follicle growth and the sur-
the direct blockade of intraovarian c-kit functions which vival of small developing follicles in the central region
were pivotal to ovarian follicle development and were not which might have started to grow prenatally (Peters, 1969).
induced by the indirect effect. These observations indicated that c-kit and SLF interaction
Of course it is still dif®cult to eliminate the possibility throughout the ®rst 5 days is necessary for the onset of
that c-kit function is necessary for some speci®c population primordial follicle development and the survival of devel-
of the extraovarian cell development or function, and those oping primary follicles.
cells play important roles in ovarian follicle development. These results are compatible with the expression of SLF
Such a possibility must also be considered even when one protein in the neonatal ovary. It is expressed on somatic
wants to analyze the phenotype of an animal with a speci®c cells around or granulosa cells within primordial follicles
mutant molecule, and is negligible only when the target in the central region of neonatal mouse ovary but not in the
organs or cells are examined after they are isolated and primordial follicles in periphery, and the strong expression
maintained under in vitro conditions. Actually, Packer et levels in the central region decreased at 4 days after birth
al. (1994) have shown the direct effects of ACK2 on oocyte (Manova et al., 1993). This also suggests that this ligand±
development by using in vitro culture system. Neverthless, receptor interaction system controlling the primary follicle
the results obtained from in vitro study sometimes dissoci- development in neonate ovary is regulated in a ligand-ex-
ate from the results obtained from in vivo study even when pression-dependent manner.
the target cells are well characterized (Lorenz et al., 1996). Once this interaction has been transiently achieved dur-
Therefore, in order to give substance to our present results ing the ®rst 5 days, like group 2 in Table 1, primary follicles
about ovarian follicle development in vivo, an in vitro ap- continue their development even with continuous antibody
proach is feasible only after the organ culture system of injection. Packer et al. (1994) have also indicated that this
mouse ovary simulating the complete process of ovarian transient activation of the c-kit in small developing oocytes
follicle development in ontogeny is established in the fu- is suf®cient to induce constant development in vitro. There
ture. are some explanations for this phenomenon.
Developing oocytes internalize c-kit and c-kit ligand (Ma-
nova et al., 1994). The pool of ligand-bound c-kit in oocytes
c-kit Is Not Necessary for Primordial Follicle may have long-lasting stimulatory effects like ligand-boundFormation but Is Necessary for Onset of Primordial
platelet-derived growth factor b-receptors, which continueFollicle Development
tyrosine phosphorylation and activation after internaliza-
tion (Sorkin et al., 1993). It is also possible that anotherThe expression of c-kit on naked oocytes through to pri-
intragonadal factor acts in parallel with and compensates formordial ovarian follicle formation suggests that it plays
the function of c-kit at these stages; otherwise, a relativelysome role in this process (Manova and Bachvarova, 1991;
Horie et al., 1991). However, regardless of the ACK2 admin- minor role in this stage development is played by c-kit.
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It has been reported that circulating levels of follicle-stim-
ulating hormone (FSH) in the newborn mouse is as high as
that of the sexually mature female mouse (Stiff et al., 1974).
But it was not apparent whether it plays a role in primary
follicle development during the neonatal period. O'Shaugh-
nessay et al. (1994) have reported that the inactive form of
FSH receptor (FSH-R) mRNA is expressed in ovary as early
as the day of birth, whereas the active form of FSH-R mRNA
was expressed only from 4 days after birth. These observa-
tions support our ®ndings that the c-kit and its ligand inter-
action have crucial roles in primary ovarian follicle develop-
ment during the ®rst 5 days after birth independent of FSH
action, and also suggest that the potential they gained dur-
ing the ®rst 5 days for survival to a later stage without c-
kit function may be to express functional FSH-R.
Oocytes May Produce the Granulosa Cell-
Proliferating Signal after c-kit Stimulation
Considering the present results, we refer to the paradox
that oocytes are the only cells that express c-kit in the early
FIG. 5. (A) Attenuated development of antral follicles of mouse
treated with ACK2 at Days 10 and 12 (group 6). (B) Blockade of preantral
follicle development in full-grown oocytes of a mouse injected with
ACK2 at Day 12±13 (group 7). (C) Attenuated incorporation of BrdU
into the follicle cells surrounding the full-grown oocytes (arrows).
FIG. 6. Many luteinized follicles found in the immature mouse
Regardless, our results indicated that the transient activa- ovary after treatment with PMSG and hCG injection (A). Degenera-
tion of c-kit during these 5 days causes the primordial folli- tion of most of the large antral follicles induced by ACK2 injected
cles to gain the potential for growth to the preantral stage 24 hr after PMSG (B). Both tissues were dissected from the mouse
at 48 hr after hCG injection.without c-kit function.
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TABLE 2
Classi®cation of the Developing Follicles in the Ovaries of Ovulation-Induced Immature Mice Injected with ACK2
Ovulated
3a 3b 4 5a 5b 6 7 eggs
Control 312 { 37 126 { 15 73 { 16 47 { 15 24 { 7 25 { 6 0.7 { 0.6 12 { 2
Group 1 238 { 35* 35 { 7* 28 { 5* 8 { 6* 5 { 4* 0 0 2 { 2*
Group 2 326 { 22 100 { 30 42 { 9* 34 { 11 22 { 4 18 { 6 0 10 { 4
Group 3 309 { 19 126 { 24 61 { 18 31 { 6* 14 { 4* 15 { 4* 1.3 { 0.8 11 { 3
Group 4 277 { 27 99 { 21* 47 { 6* 28 { 8* 19 { 6 10 { 3* 0 10 { 3
Group 5 278 { 24 74 { 15* 36 { 6* 14 { 8* 7 { 4* 2 { 2* 0 5 { 2*
Group 6 313 { 34 107 { 22 51 { 8 35 { 10 22 { 7 17 { 3* 0.8 { 0.8 10 { 3
Group 7 307 { 29 120 { 12 93 { 21 32 { 8 17 { 7 20 { 8 0.8 { 0.8 11 { 3
AVAS12au 298 { 46 116 { 30 60 { 22 38 { 14 19 { 7 18 { 8 1.2 { 1.2 12 { 2
Note. Control group was treated with daily injection of PBS from Day 24 to 27 in combination with administration of PMSG at Day
24 and hCG at 48 hr after PMSG injection. The dates of ACK2 injection into experimental groups are indicated in Fig. 7 as cells typed
ACK2. 500 mg of AVAS12 a was intraperitoneally injected from Day 24 to 27 in combination with administration of PMSG at Day 24
and hCG at 48 hr after PMSG injection. The numbers of ovulated oocytes were counted in whole oviducts from ®mbula to uterine horn
by serial sections. The total number of oviducts con®rmed for counting ovulated oocytes was four in this group. Mean number { SD; n
 6 (from three mice) for each group; u; n  4 (from two mice) for each group.
* P  0.05 (Student's t test). Ovulated eggs: the number of eggs in oviducts.
postnatal ovary. However, the cessation of proliferation of oocytes may transduce the signal by small molecules pass-
ing through the junction. One candidate is cyclic AMPgranulosa cells surrounding the oocyte is the most signi®-
which passes through the gap junction from astrocyte tocant effect induced by ACK2 administration. This paradox
granulosa cells and mimics the function of FSH in in vitrosuggests the presence of a granulosa cell proliferation signal
cocultures (Lawrence et al., 1978). Because cyclic AMP isderived from oocytes activated by SLF and c-kit interaction.
produced not only in granulosa cells but also in oocytesIf so, the question remains as to how the signal is transduced
(Sato and Koide, 1984; Bornslaeger and Schultz, 1985), thefrom the oocyte to the granulosa cells.
activated oocyte may transduce cyclic AMP and proliferateThe membrane-bound form of SLF must not transduce
immature granulosa cells without expressing functionalthe signal into granulosa cells directly through its cyto-
FSH-R.plasmic domain, because the aberrant cytoplasmic domain
Another possibility is the presence of a secreted factorof Mgf Sl-17H/Mgf Sl-17H mutant mouse SLF has no effect on
from oocyte. Vanderhyden et al. (1992) have identi®ed aovarian follicle development (Brannan et al., 1992).
granulosa cell-proliferating factor derived from oocytes inSince gap junctions between oocyte and granulosa cells
preantral follicles of the mouse. Epidermal growth factor,are recognized even in the primordial follicles of the prena-
which causes granulosa cells to proliferate, is secreted fromtal mouse ovary (Mitchel and Burghardt, 1986), activated
the porcine oocyte in the developing follicle (Singh et al.,
1995). The ®nding that growth and differentiation factor 9
(GDF-9), a member of the TGF-b superfamily, is speci®cally
expressed in developing mouse oocytes also suggested that
it may play a role in granulosa cell development (McGrath
et al., 1994). Very recently, GDF-9-de®cient mouse was pro-
duced and actually shown to have a defect in early ovarian
folliculogenesis (Dong et al., 1996). Since the stage of ovar-
ian folliculogenesis disturbed in this gene-manipulated
mouse was similar to that of ACK2-treated mice, GDF-9
may be the candidate for a granulosa cell-proliferating factor
produced from oocytes activated via c-kit.
We are currently investigating the difference in the ex-
pressed mRNAs or proteins in the ovaries between ACK2-
injected and untreated newborn mice.
FIG. 7. The experimental schedule for ACK2 injection into ovula- Follicular Fluid Formation Requires c-kit and Itstion- induced mice. Five hundred micrograms of ACK2 was injected
Ligand Interactionat each injection. The notable effect of antibody treatment speci®c
Antrum formation is a primary characterization of devel-to this stage was blockade of penultimate-stage preovulatory folli-
cle development resulting in ovulation number reduction. oping follicles in which the oocyte has reached full size. It
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TABLE 3
Classi®cation of the Developing Follicles in the Ovaries of Adult Mice Injected with ACK2
3a 3b 4 5a 5b 6 7
Control 127 { 24 65 { 18 52 { 5 15 { 2 8 { 2 3 { 1 0
Treated 77 { 24* 42 { 14* 26 { 9* 15 { 6 5 { 2 1 { 1 0
Note. Control, ovaries from 8-week-old mice treated with daily PBS injections for 7 days. Treated, ovaries from 8-week-old mice given
daily ACK2 injections of 500 mg for 7 days. In every ovary, 200 serial sections of 5-mm thickness starting from the maximal diameter
specimen to both sides were examined. Mean number { SD; n  4 (from two mice) for each group.
* P  0.05 (Student's t test).
begins with the uptake or accumulation of follicular ¯uid luteal cell development (Motro and Bernstein, 1993). How-
ever the results of our timed ACK2 administration, aroundbetween some granulosa cells, resulting in the formation of
a small internal cavity at one pole of the oocyte. Both oo- 12 or 24 hr before hCG, did not correlate with the above-
described timing of SLF mRNA expression.cytes and granulosa cells are thought to contribute to this
process (Hirsh®eld, 1991). We questioned why the survival of the penultimate-stage
ovarian follicle is blocked by a c-kit function blockade. Oo-Our results indicate that the follicular ¯uid forming pro-
cess of the preantral, secondary follicle is actually regulated cytes have important roles in the development of ovarian
follicles even in this penultimate stage. For example, Eppigby c-kit and its ligand interaction. It must be noted that
in these secondary follicles, a blockade of c-kit function et al. have detected an oocyte-derived soluble factor neces-
sary for cumulus cell expansion during the development ofdisturbed the granulosa cell proliferation more severely
than that of small developing follicles. Considering reports the preovulatory follicle (reviewed by Eppig, 1994). Inactiva-
tion of the c-kit function might have negative effects onof the intensive expression of the SLF mRNA in preantral
follicle granulosa cells compared with that of small devel- oocyte development in penultimate-stage follicles and re-
sult in preovulatory follicle degeneration. Very recently, Is-oping follicles (Motro and Bernstein, 1993; Manova et al.,
1993), ovarian follicles must require this receptor and ligand mail et al. (1996) have shown the intensive expression of
SLF mRNA and protein in the cumulus cells of large antralinteraction system at this stage and oocytes may have a
crucial role in granulosa cell proliferation or differentiation follicles of rat ovary and have indicated it will maintain the
meiotic arrest during the oocyte growth in this penultimate-for antrum formation because they are the only cells ex-
pressing c-kit at this stage. stage follicle. Although it is the case in rat and contrary to
the SLF mRNA expression pattern in mouse (Motro and
Bernstein, 1993), meiotic maturation of intrafollicular oo-
Distinct Steps of Antral Follicle Development Are cyte might be the cause of preovulatory follicle degenera-
Regulated by c-kit and Its Ligand Interaction tion by ACK2 injection.
For future study, however, it is necessary to assay subtleThe antral follicle-atresion process, the most crucial
changes in the function of theca cells upon stimulation orbranching point in follicle development leading to the ovu-
a blockade of c-kit function in vitro. This may reveal a rolelatory stage, is thought to be systematically regulated by
of c-kit in theca cell function during preovulatory folliclegonadotropin secretion (Hirsh®eld and Midgrey, 1978). In
development and luteinization that has been overlooked orcontrast to the blockade of primary follicle development,
unidenti®ed by our histological ®ndings in vivo.the survival of small antral follicles in the presence of exoge-
nous PMSG administrated with ACK2 suggests that c-kit
does not play an important role or that another intrafollicu- c-kit Is Not Necessary for the Survival of Dormant
lar system of growth factors (see review by Hsueh et al., Primordial Follicles
1994) may compensate for the c-kit function in small antral
follicle development. It is notable that none of the mice were rendered sterile
by ACK2 administration under our conditions. This resultIn contrast, our results indicate the necessity of c-kit
function for a rather late stage of antral follicle develop- indicated that c-kit is not necessary for the survival of resid-
ual primordial follicle, in contrast to the de®nite necessityment. Large antral follicles that escaped branching toward
spontaneous atresia must follow a ®nal differentiation pro- for the survival of migrating germ cells during the early
embryonic stage (Yoshida et al., 1993) and of developingcess to ovulation. Since mural but not other types of granu-
losa cells in large antral follicles express SLF mRNA in follicles. This is also true of spermatogenesis in the testis
(Yoshinaga et al., 1991), melanogenesis in cycling hair folli-response to an LH surge in mouse, it was suggested that c-
kit expressed on the theca cells just above the mural granu- cles (Nishikawa et al., 1991; Yoshida et al., 1993, 1996),
and long-term hematopoiesis in bone marrow (Ogawa et al.,losa cells plays important roles in preovulatory follicle and
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FIG. 8. Scheme of the stepwise requirement of c-kit in mouse ovarian follicle development in vivo. (1) Naked oocytes are surrounded
by granulosa cells and render the primordial follicles independent of c-kit function. (2) Primordial follicles start to develop dependent
upon c-kit function. (3) Once primordial follicle development has started, it is not completely dependent on c-kit. (4) When those small
follicles become preantral follicles, they again require c-kit function in antrum formation. (5) Antral follicles develop despite a c-kit
function blockade. (6) However, they do not become ovulated without c-kit at the penultimate stage. (7) Ovulated follicles do not require
c-kit for luteinization.
1991, 1993). These results indicate that c-kit is necessary example, KitW-42J// mouse which shows almost white coat
for the differentiation or survival of the cells that have ad- color, severe anemia, and reduction in ovarian follicular
vanced from stem cell pools, but not for the maintenance number but is viable and fertile, were shown to have a
of dormant stem cells. missense mutation in the coding region of the c-kit kinase
domain (Tan et al., 1990). This mutant c-kit molecule was
shown to have a dominant negative effect on wild-type c-
Difference between Ovarian Follicle Development kit molecule when the heterodimer was formed (Ray et al.,
of ACK2-Injected Mice and That of Some Mutant 1991), similar to the other mutants KitW-37J, KitW-v, and
Mice at Mgf or Kit Locus KitW-41J (Reith et al., 1990; Nocka et al., 1990; Reith and
Bernstein, 1992). Why does the same mutation of the c-kitPresent result indicate the stepwise requirement of c-kit
molecule in each cell result in cell-type-speci®c defects inin mouse ovarian follicle development. However, appar-
these mutant mice? The perturbed speci®ty of substrateently normal folicular development was reported in Kit and
association and phosphorylation of c-kit cytoplasmic do-Mgf mutations that are so severe that the actual number of
main might have induced the cell-type-speci®c defects infollicles is dramatically reduced and pigmentation and/or
these mutant mice (Reith et al., 1991; Herbst et al., 1992).hematopoiesis are severely affected (see review of Besmer
It is also possible that regulation of the signal from c-kitet al., 1993; Galli et al., 1994).
varies in a cell-type-speci®c manner (Lorenz et al., 1996).Spatially or temporally aberrant expression of wild-type
But we think these cell-type-speci®c defects indicate, atSLF molecule is suggested to be the main cause of cell-type-
least in part, that the threshold levels of c-kit function req-speci®c defect found in Mgf Sl-pan or Mgf Sl-con mutant mice
uisite for each organ or cell may differ. Ovarian follicle(Huang et al., 1993; Bedell et al., 1995). This type of muta-
development may require lower level of c-kit function thantion was also reported in some cases of Kit or Pdgfra locus
melanogenesis, erythropoiesis, or primordial germ cell de-mutant, KitW-Sh or PdgfraPh (Duttlinger et al., 1993, 1995).
velopment. Our previous antibody injection studies haveAn aberrant cytoplasmic domain of the SLF molecule found
shown that melanogenesis (Nishikawa et al., 1991; Yoshidain Mgf Sl-17H/Mgf Sl-17H mutant mice with cell-type-speci®c
et al., 1993, 1996; Okura et al., 1995), hematopoiesis (Ogawadefects indicated the important roles of the membrane-
et al., 1991), primordial germ cell development (Yoshida etbound form of SLF in melanogenesis and spermatogenesis
al., 1993), and spermatogenesis (Yoshinaga et al., 1991) are(Brannan et al., 1992). It is reasonable that the results ob-
very easily blocked by a relatively lower dose of ACK2 thantained by function blocking of c-kit by ACK2 were different
that which blocks ovarian folliculogenesis. This suggestsfrom phenotypes of above-mentioned mutant mice.
On the other hand, some of the mutants in Kit locus, for the requisite dose of a speci®c molecule for individual cells
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Comprehensive Synthesis'' (L. W. Browder, Ed.), Vol. 1, pp. 453±in different organs varies according to their lineages or dif-
524. Plenum, New York.ferentiating stages or, vice versa, indicates that to discover
Bedell, M. A., Brannan, C. I., Evans, E. P., Copeland, N. G., Jenkins,the precise role of an extracellular or transmembrane mole-
N. A., and Donovan, P. J. (1995). DNA rearrangements locatedcule in ontogeny, function-blocking antibody injection
over 100 kb 5* of the Steel (Sl)-coding region in Steel-panda andstrategy is superior to the usual homologous recombination
Steel-contrasted mice deregulate Sl expression and cause female
strategy to make a null mutant of the molecule. sterility by disrupting ovarian follicle development. Genes Dev.
Finally, this is the ®rst identi®cation of an intragonadal 8, 455±470.
receptor and ligand interaction system that regulates the Benett, D. (1956). Developmental analysis of a mutation with pleio-
mammalian small ovarian follicle development indepen- tropic effects in the mouse. J. Morphol. 98, 199±233.
dent of gonadotropin regulation in vivo. It also became ap- Besmer, P., Manova, K., Duttlinger, R., Huang, E. J., Packer, A.,
Gyssler, C., and Bachvarova, R. (1993). The kit-ligand (steel fac-parent that the ®rst 5 days after birth is the de®nitive period
tor) and its receptor c-kit/W: Pleiotropic roles in gametogenesisduring which mouse ovarian follicle growth is initiated by
and melanogenesis. Development (Suppl.), 125±137.this local factor. In addition, c-kit and its ligand seem to play
Bornslaeger, E. A., and Schultz, R. M. (1985). Adenylate cyclase ac-important roles in follicular ¯uid formation of preantral
tivity in zona-free mouse oocytes. Exp. Cell Res. 156, 277±281.follicles and the survival or development of preovulatory
Brannan, C. I., Bedell, M. A., Resnick, J. L., Eppig, J. J., Handel,follicles. These ®ndings can only be con®rmed by tempo-
M. A., Williams, D. E., Lyman, S. D., Donovan, P. J., Jenkins,
rally speci®c function blocking by antibody administration. N. A., and Copeland, N. G. (1992). Developmental abnormalities
Figure 8 shows a scheme of c-kit function during mouse in Steel17H mice result from a splicing defect in the steel factor
ovarian folliculogenesis from the primordial follicle to the cytoplasmic tail. Genes Dev. 6, 1832±1842.
corpus luteum. Byskov, A. G. (1986). Differentiation of mammalin embryonic go-
Our ®ndings of a stepwise requirement for c-kit and its nad. Physiol. Rev. 66, 71±117.
Chabot, B., Stephenson, D. A., Chapman, V. M., Besmer, P., andligand in ovarian follicle development will be helpful in
Bernstein, A. (1988). The proto-oncogene c-kit encoding a trans-clarifying the mechanism of some sporadic types of infertil-
membrane tyrosine kinase receptor maps to the mouse W locus.ity induced by intragonadal defects of hitherto unknown
Nature 335, 88±89.causes (Friedman et al., 1983; Aiman and Smentek, 1985).
Copeland, N. G., Gilbert, D. B., Cho, B. C., Donovan, P. J., Jenkins,There may be an example in which a defect in the regional
J. A., Cosman, D., Anderson, D., Lyman, S. D., and Williams,or temporal expression of the SLF gene in the ovary after
D. E. (1990). Mast cell growth factor maps near the steel locus
sexual maturation occurs in the Mgf Sl-con/Mgf Sl-con mutant on mouse chromosome 10 and is deleted in a number of Steel
mouse (Bedell et al., 1995). Like the success of a single alleles. Cell 63, 175±183.
administration of recombinant M-CSF in curing congenital Dong, J., Albertini, D. F., Nishimori, K., Kumar, T. R., Lu, N., and
osteopetrosis in the Csfmop/Csfmop mutant mouse (Kodama Matzuk, M. M. (1996). Growth differentiating factor-9 is required
et al., 1993), the appropriate administration of recombinant during early ovarian folliculogenesis. Nature 383, 531±535.
Duttlinger, R., Manova, K., Chu, T. Y., Gyssler, C., Zelenetz, A. D.,SLF may provide a new means of treating female infertility
Bachvarova, R. F., and Besmer, P. (1993). W-sash affects positiveof unknown causes.
and negative elements controlling c-kit expression: Ectopic c-kit
expression at sites of kit-ligand expression affects melanogenesis.
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